Ardent Health, Inc.
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Revenue | $1.47B | $1.44B | $1.38B | $1.37B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $29.1M | $32.9M | $29.0M | $26.7M |
| Operating Income | $82.2M | $56.6M | $46.0M | $67.8M |
| Operating Margin | 5.6% | 3.9% | 3.3% | 5.0% |
| Interest Expense | — | — | — | — |
| Pretax Income | $82.2M | $56.6M | $46.0M | $67.8M |
| Income Tax Expense | $15.2M | $10.7M | $7.3M | $12.1M |
| Net Income | $42.8M | $27.0M | $20.8M | $33.1M |
| Net Margin | 2.9% | 1.9% | 1.5% | 2.4% |
| EPS (Basic) | $0.34 | $0.21 | $0.17 | $0.26 |
| EPS (Diluted) | $0.34 | $0.21 | $0.17 | $0.26 |
| Shares Outstanding (Basic) | 126.1M | 126.1M | 126.1M | 126.1M |
| Shares Outstanding (Diluted) | 126.1M | 126.1M | 126.1M | 126.1M |
| Dividends Per Share | — | — | — | — |